|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-4-27
|
|
pubmed:abstractText |
Mesenchymal stem cells (MSCs) are a promising vehicle for targeted cancer gene therapy because of their potential of tumor tropism. For efficient therapeutic application, we developed retroviral vector-producing MSCs that enhance tumor transduction via progeny vector production.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1521-2254
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2009 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
373-81
|
|
pubmed:meshHeading |
pubmed-meshheading:19274675-Animals,
pubmed-meshheading:19274675-Cell Death,
pubmed-meshheading:19274675-Cell Line, Tumor,
pubmed-meshheading:19274675-Cell Survival,
pubmed-meshheading:19274675-Gene Dosage,
pubmed-meshheading:19274675-Gene Therapy,
pubmed-meshheading:19274675-Genes, Transgenic, Suicide,
pubmed-meshheading:19274675-Genetic Vectors,
pubmed-meshheading:19274675-Humans,
pubmed-meshheading:19274675-Mesenchymal Stem Cells,
pubmed-meshheading:19274675-Neoplasms,
pubmed-meshheading:19274675-Rats,
pubmed-meshheading:19274675-Retroviridae,
pubmed-meshheading:19274675-Transduction, Genetic
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
|
|
pubmed:affiliation |
Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
